BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20399893)

  • 1. Phospholipase D in brain function and Alzheimer's disease.
    Oliveira TG; Di Paolo G
    Biochim Biophys Acta; 2010 Aug; 1801(8):799-805. PubMed ID: 20399893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking lipids to Alzheimer's disease: cholesterol and beyond.
    Di Paolo G; Kim TW
    Nat Rev Neurosci; 2011 May; 12(5):284-96. PubMed ID: 21448224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol trafficking and amyloid beta peptides.
    Wood WG; Igbavboa U
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S144-8. PubMed ID: 14574629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.
    Haass C; Selkoe DJ
    Nat Rev Mol Cell Biol; 2007 Feb; 8(2):101-12. PubMed ID: 17245412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipase D1 is up-regulated in the mitochondrial fraction from the brains of Alzheimer's disease patients.
    Jin JK; Kim NH; Lee YJ; Kim YS; Choi EK; Kozlowski PB; Park MH; Kim HS; Min do S
    Neurosci Lett; 2006 Oct; 407(3):263-7. PubMed ID: 16973278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
    Hardy J
    J Neurochem; 2009 Aug; 110(4):1129-34. PubMed ID: 19457065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
    Haughey NJ; Bandaru VV; Bae M; Mattson MP
    Biochim Biophys Acta; 2010 Aug; 1801(8):878-86. PubMed ID: 20452460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's.
    Wyss-Coray T
    Curr Alzheimer Res; 2006 Jul; 3(3):191-5. PubMed ID: 16842094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients.
    Kanfer JN; Hattori H; Orihel D
    Ann Neurol; 1986 Aug; 20(2):265-7. PubMed ID: 3019230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta protein disruption of cholinergic and growth factor phospholipase C signals could underlie cognitive and neurodegerative aspects of Alzheimer's disease.
    Crews FT
    Neurobiol Aging; 1994; 15 Suppl 2():S95-6. PubMed ID: 7700473
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of cytosolic phospholipase A2 α in amyloid precursor protein induction by amyloid beta1-42 : implication for neurodegeneration.
    Sagy-Bross C; Kasianov K; Solomonov Y; Braiman A; Friedman A; Hadad N; Levy R
    J Neurochem; 2015 Mar; 132(5):559-71. PubMed ID: 25533654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease.
    Hirsch-Reinshagen V; Wellington CL
    Curr Opin Lipidol; 2007 Jun; 18(3):325-32. PubMed ID: 17495608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease.
    Jin JK; Ahn BH; Na YJ; Kim JI; Kim YS; Choi EK; Ko YG; Chung KC; Kozlowski PB; Min do S
    Neurobiol Aging; 2007 Jul; 28(7):1015-27. PubMed ID: 16797788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.
    Carvalho C; Correia SC; Santos RX; Cardoso S; Moreira PI; Clark TA; Zhu X; Smith MA; Perry G
    J Bioenerg Biomembr; 2009 Oct; 41(5):433-40. PubMed ID: 19830532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta precursor protein processing in neurodegeneration.
    Wilquet V; De Strooper B
    Curr Opin Neurobiol; 2004 Oct; 14(5):582-8. PubMed ID: 15464891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease.
    Pluta R
    Curr Neurovasc Res; 2004 Dec; 1(5):441-53. PubMed ID: 16181092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.